{"id":"W2142330668","doi":"10.3109/10428194.2014.894190","title":"Prolonged progression-free survival and preserved quality of life in the Canadian prospective study of tositumomab and iodine<sup>131</sup>-tositumomab for previously treated, rituximab-exposed, indolent non-Hodgkin lymphoma","year":2014,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; University of Calgary; GlaxoSmithKline (Canada); Centre Hospitalier de l’Université de Montréal","funders":"GlaxoSmithKline","keywords":"Medicine; Internal medicine; Rituximab; Radioimmunotherapy; Oncology; Adverse effect; Lymphoma; Gastroenterology; Immunology; Antibody; Monoclonal antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006134663,0.0003354546,0.000349902,0.0003516732,0.001012436,0.0007408871,0.0004446868,0.0003673444,0.0006777972],"category_scores_gemma":[0.001000576,0.000231238,0.0004823267,0.0007554096,0.0004184583,0.0002357102,0.0003101438,0.0006338817,0.00008286774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00340017,"about_ca_system_score_gemma":0.003633648,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4079562,"about_ca_topic_score_gemma":0.4964114,"domain_scores_codex":[0.9996161,0.00005199042,0.00001961959,0.00004273256,0.0001295712,0.000139968],"domain_scores_gemma":[0.999151,0.0000614383,0.000236732,0.000030643,0.0001728628,0.0003473435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001321982,0.000156493,0.9942363,0.00001436264,0.00009167677,0.0001823123,0.0001851507,0.00008380415,0.0007803558,0.00002028538,0.0001862117,0.002741236],"study_design_scores_gemma":[0.00005919471,0.0003639072,0.9987628,0.000003560921,0.00003700786,0.0001697629,0.00009062523,0.0001393055,0.00006041751,0.000007357236,0.0003013282,0.000004717315],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994214,0.0001726316,0.00001696703,0.00003528962,0.000002312487,0.00001289307,0.0001322434,0.000001493231,0.0002049228],"genre_scores_gemma":[0.9994484,0.0000596903,0.00002964105,0.00004504982,0.000004036925,0.000005142635,0.0002924,9.152604e-7,0.0001147741],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5920438,"threshold_uncertainty_score":0.8111633,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02187126582969337,"score_gpt":0.27748041892764,"score_spread":0.2556091530979466,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}